Learn About Acute Posterior Multifocal Placoid Pigment Epitheliopathy

What is the definition of Acute Posterior Multifocal Placoid Pigment Epitheliopathy?
Acute posterior multifocal placoid pigment epitheliopathy (APMPPE) is an acquired, inflammatory eye condition affecting the retina, retinal pigment epithelium (pigmented layer of the retina), and choroid. It usually affects both eyes and is characterized by multiple, yellow-white lesions in the back of the eye. The condition can significantly impair visual acuity if the macula is involved. APMPPE typically resolves on its own in weeks to months. While the cause is unknown, about a third of cases appear to develop after a flu-like illness. Non-ocular symptoms are uncommon, but cerebral vasculitis can be present and may cause permanent and/or severe neurological complications.
Save information for later
Sign Up
What are the alternative names for Acute Posterior Multifocal Placoid Pigment Epitheliopathy?
  • Acute posterior multifocal placoid pigment epitheliopathy
  • AMPPE
  • APMPPE
  • Acute multifocal placoid pigment epitheliopathy
  • Acute placoid pigment epitheliopathy
  • Epitheliopathy, acute posterior multifocal placoid pigment
  • Multifocal placoid pigment epitheliopathy
Who are the top Acute Posterior Multifocal Placoid Pigment Epitheliopathy Local Doctors?
Elite
Highly rated in
11
conditions

Centre For Ophthalmic Specialized Care

Retinal And Inflammatory Eye Diseases, Clinic Montchoisi Teaching Centre 
Lausanne, VD, CH 

Carl Herbort is in Lausanne, Switzerland. Herbort is rated as an Elite expert by MediFind in the treatment of Acute Posterior Multifocal Placoid Pigment Epitheliopathy. He is also highly rated in 11 other conditions, according to our data. His top areas of expertise are Acute Posterior Multifocal Placoid Pigment Epitheliopathy, Vogt-Koyanagi-Harada Disease, Uveitis, and Serpiginous Choroiditis.

Elite
Highly rated in
9
conditions

Ophthalmology Center For Imaging And Laser

Paris, FR 75012

Sarah Mrejen is in Paris, France. Mrejen is rated as an Elite expert by MediFind in the treatment of Acute Posterior Multifocal Placoid Pigment Epitheliopathy. She is also highly rated in 9 other conditions, according to our data. Her top areas of expertise are Acute Posterior Multifocal Placoid Pigment Epitheliopathy, Central Serous Chorioretinopathy, Serpiginous Choroiditis, and Age-Related Macular Degeneration ARMD.

 
 
 
 
Learn about our expert tiers
Learn more
Elite
Highly rated in
20
conditions
Ophthalmology

Vitreous Retina Macula Consultants Of NY

460 Park Ave 
New York, NY 10022

Lawrence Yannuzzi is an Ophthalmologist in New York, New York. Dr. Yannuzzi has been practicing medicine for over 58 years and is rated as an Elite doctor by MediFind in the treatment of Acute Posterior Multifocal Placoid Pigment Epitheliopathy. He is also highly rated in 20 other conditions, according to our data. His top areas of expertise are Coats Disease, Acute Posterior Multifocal Placoid Pigment Epitheliopathy, Punctate Inner Choroidopathy, and Central Serous Chorioretinopathy. He is licensed to treat patients in New York. Dr. Yannuzzi is currently accepting new patients.

What are the latest Acute Posterior Multifocal Placoid Pigment Epitheliopathy Clinical Trials?
Longitudinal Cohort Study of Patients With Birdshot Chorioretinopathy.
Match to trials
Find the right clinical trials for you in under a minute
Get started
Punctate Inner Choroidopathy (PIC) and Its Role in Progression of Pathological Myopia
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Acute Posterior Multifocal Placoid Pigment Epitheliopathy?
Recurrent Vertebrobasilar Strokes Associated With Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE).
Optical coherence tomography angiography (OCTA) findings in Serpiginous Choroiditis.
Tired of the same old research?
Check Latest Advances
Long-Term Outcome of Punctate Inner Choroidopathy or Multifocal Choroiditis with Active Choroidal Neovascularization Managed with Intravitreal Bevacizumab.